In March 2025, the company introduced new options for any direct-to-shopper offering of its Wegovy weight loss drug. The company founded a fresh pharmacy, identified as NovoCare, which would cost shoppers $499 monthly for use of the drug, lower than half the expense of the drug through other pharmaceutical distribution networks.[fifty three]Facts: